Abstract
A retrospective case-control study of 12 patients positive for Stenotrophomonas maltophilia and 24 age-sex-matched controls revealed that in the year prior to initial isolation, colonised patients spent more days in hospital and received more days of oral ciprofloxacin, intravenous anti-pseudomonal antibiotics, and nebulised aminoglycosides. They were also more likely to have grown Pseudomonas aeruginosa at some time in the past, despite there being no difference in current chronic infection with this organism. The role of anti-pseudomonal antibiotics in promoting Stenotrophomonas maltophilia colonisation in cystic fibrosis is discussed.
MeSH Terms
Adolescent
Aminoglycosides
Anti-Bacterial Agents/pharmacology,therapeutic use
Case-Control Studies
Child
Child, Preschool
Chronic Disease
Cystic Fibrosis/complications
Female
Humans
Male
Microbial Sensitivity Tests
Pseudomonas Infections/complications,drug therapy
Pseudomonas aeruginosa/drug effects,isolation & purification
Retrospective Studies
Treatment Outcome
Chemicals
Aminoglycosides
Anti-Bacterial Agents
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Denton M
Department of Microbiology, St. James's University Hospital, Leeds, UK.
Todd N J
Littlewood J M
References (11)
11 references, click to expand
-
Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer.
Rev Infect Dis. 1990 Nov-Dec;12(6):997-1003
PMID: 2267495
-
Stenotrophomonas maltophilia in cystic fibrosis patients.
Eur J Clin Microbiol Infect Dis. 1995 Aug;14(8):728-9
PMID: 8565998
-
The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia.
J Hosp Infect. 1995 Jun;30 Suppl:453-64
PMID: 7560984
-
Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis.
Arch Dis Child. 1992 Feb;67(2):192-5
PMID: 1371914
-
Epidemiological typing of Stenotrophomonas (Xanthomonas) maltophilia by PCR.
J Clin Microbiol. 1995 Apr;33(4):912-4
PMID: 7790459
-
Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis.
Lancet. 1985 Apr 13;1(8433):865
PMID: 2858720
-
Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro.
Antimicrob Agents Chemother. 1992 Mar;36(3):669-71
PMID: 1622183
-
Use of antibiotics in cystic fibrosis. The Danish approach.
Antibiot Chemother (1971). 1989;42:237-46
PMID: 2688545
-
Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis.
J Clin Microbiol. 1996 Mar;34(3):584-7
PMID: 8904419
-
Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis.
Acta Paediatr. 1993 Mar;82(3):308-9
PMID: 8495091
-
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.
Lancet. 1991 Sep 21;338(8769):725-6
PMID: 1679870